Top Telehealth Companies With Best Stability & Growth (388)

Market Expansion: Market Expansion: Nationwide telehealth availability and launches into additional categories beyond obesity care indicate an expanding geographic and service footprint. Company posts and event sponsorships reinforce ongoing outreach consistent with a scale-up trajectory.

Product Line Growth: Product Line Growth: An actively updated iOS app and refreshed online platform, together with new specialty areas, show continued investment in product and service breadth. The organization appears to be evolving from a single-category clinic toward a broader digital health offering.

Strong Hiring & Retention: Strong Hiring & Retention: Frequent role postings on professional networks and visible employer-brand activity point to active headcount growth. Hiring across functions such as marketing and design suggests support capabilities are being built alongside core clinical and product teams.

Profitability: Recent results indicate high operating leverage with strong margins and cash generation even as the top line expands. Management reported robust profitability alongside growing engagement and product adoption.

Strong Revenue Growth: Fiscal results and current-year guidance point to ongoing double‑digit revenue expansion from a larger base. Quarterly performance remained year‑over‑year positive despite variability between periods.

Strong Market Position & Advantage: Company disclosures indicate reach to a large majority of U.S. physicians with record engagement across newsfeed, workflow, and AI tools. Widely used telehealth and workflow utilities reinforce defensibility with clinicians.

Profitability: Signals indicate the company returned to profitability by 2023 and maintained profitable growth into 2024–2025, reflecting increased financial stability.

Strong Market Position & Advantage: Public materials portray the firm as a category leader in U.S. consumer doctor discovery and real-time booking, operating at national scale with millions of bookings.

Strategic Partnerships: Recent integrations with organizations like Blue Shield of California, Healthgrades, Yelp, and large health systems expand distribution and reinforce platform reach.

Market Expansion: Public materials indicate a materially larger member footprint than earlier years, with reported reach in the 26–28 million range across the U.S. and Latin America. Partnerships such as AXA Partners Mexico and activity in Brazil reinforce expansion beyond the core U.S. market.

Product Line Growth: New AI-enabled collaboration features in 2024 and the 2025 launch of Pager Health Navigator broaden platform scope and aim to unify provider, clinical, benefits, and program navigation. These additions signal active investment to capture more workflow within payer ecosystems.

Investor Backing & Capital Strength: Funding disclosures from 2020 and 2021 bring total capital above $120M, providing a base to support multi‑year product and commercial scaling. This capital position underpins continued go‑to‑market execution and platform development.

Investor Backing & Capital Strength: The company raised sizable Series A and B rounds totaling well over $100M and was reported at a unicorn valuation, signaling strong investor confidence and runway. Funding momentum closely followed rapid operational scaling across patients and providers.

Profitability: The company is described as profitable despite rapid expansion, an uncommon outcome among digital health peers. This indicates financial discipline alongside continued investment in growth and product.

Strategic Partnerships: Extensive in‑network relationships with major commercial, Medicare, and Medicaid plans and collaborations with health systems broaden access and distribution. Most patients are able to pay nothing out of pocket through these arrangements.

Investor Backing & Capital Strength: Available disclosures indicate Marble closed a $15.5M Series A in Oct 2025 led by Costanoa with Town Hall Ventures and Khosla Ventures participating, adding to earlier seed capital. Feedback suggests this funding is earmarked for hiring, product development, and national rollout.

Market Expansion: Company communications and filings indicate recent launches in Ohio and New Jersey alongside an Ohio legal registration, pointing to a widening footprint beyond its New York base. Feedback suggests ongoing school partnership announcements and active hiring align with multi-state go-to-market execution.

Strategic Partnerships: Public materials highlight growing school partnerships and insurer alignment, with care marketed as in-network and inclusive of Medicaid. Feedback suggests this school-embedded, insurance-billed model is gaining traction amid strong policy tailwinds for youth mental health access.

Strategic Partnerships: Public partnerships with MetLife, New York Life, Securian, and others—along with the insurer coalition formed via the “Empathy Alliance”—point to deep carrier integrations and strong distribution leverage. These relationships indicate large carriers are standardizing on Empathy for post‑claim experience in the U.S. life channel.

Investor Backing & Capital Strength: Closing a $72M Series C in May 2025 (total funding roughly $162M) with participation from top VCs and major insurers signals strong financial support. This unusual mix of capital and distribution partners provides resources and validation for scaling in a young category.

Market Expansion: Geographic expansion into Canada and the U.K., with partnerships such as Sun Life, TD Bank, and BMO Insurance, shows momentum beyond the U.S. base. Additional carrier deals and claims coverage across North America broaden reach into tens of millions of policyholders.

Strong Revenue Growth: The company reports sharply increasing revenue year over year alongside expanding operations. This indicates accelerating commercial momentum with national health plans.

Investor Backing & Capital Strength: The company has secured substantial funding from prominent investors, including a recent Series B, to fuel technology and market expansion. This capital position supports continued scaling across teams and geographies.

Market Expansion: The company has rapidly grown its multi-state footprint and reached significant in-home visit volume. Feedback suggests this reflects repeatable execution across diverse markets and populations.

Strong Revenue Growth: Repeated inclusion on the Inc. 5000 and Deloitte Technology Fast 500, alongside management attribution to rising demand, indicates sustained top-line expansion. Reported improvements in ARR from 2018 to 2022 further support a multi‑year growth trajectory.

Market Expansion: Multiple acquisitions (e.g., Joshin, ABA Therapy Billing & Insurance Services, Total Therapy, TheraWe) and integrations (e.g., Netsmart, Raintree) broaden geographic reach and segment coverage. Company materials cite global utilization across many countries and penetration into large employers, school districts, and provider networks.

Innovation-Driven Growth: Launches such as the RethinkBH AI Dashboard and Session Note AI, plus ecosystem integrations, signal ongoing product investment that can unlock new use cases and upsell opportunities. A commissioned TEI study highlighting ROI for employers provides added validation of innovation-linked value.

Investor Backing & Capital Strength: Recent announcements of a $32M Series A (March 2024) and an oversubscribed $50M Series B (April 2025, including $20M credit) indicate strong access to capital. These rounds are positioned to fund product expansion, go‑to‑market, and hiring.

Strategic Partnerships: The TriNet collaboration (October 2023, highlighted again in May 2025) and joining the Workday Wellness Program (April 2026) show expanding distribution through major HR platforms. These channels enhance reach into SMB and broader employer segments.

Market Expansion: Company communications and coverage cite surpassing 15,000 customers and momentum in the mid‑market. Channel distribution via platforms like TriNet is presented as widening access to employer groups.

Market Expansion: Active hiring across multiple functions, multi‑state therapist directories on the site, and new senior‑care partnerships indicate the company is broadening geographic reach and access channels.

Strategic Partnerships: Being in‑network with Medicare and collaborating with Advanced Nursing & Home Care suggest integration within senior‑care ecosystems that can accelerate referrals and distribution.

Innovation-Driven Growth: An AI‑native operating system with virtual therapy, care navigation, and AI agents points to a technology‑led approach designed to scale services efficiently.

Strong Revenue Growth: Signals since late 2024 point to reacceleration, with independent estimates indicating substantial GLP‑1 revenue and overall momentum despite the company being private.

Strategic Partnerships: Direct integrations with Eli Lilly’s LillyDirect (Dec 2024) and Novo Nordisk’s NovoCare (Apr 2025), plus continued collaboration into 2026 for the Wegovy pill, expand supply reliability and lower cash costs for eligible patients.

Market Expansion: The rapidly expanding GLP‑1 market and Ro’s inclusion among named telehealth partners, including launch support for the Wegovy pill, position the company to capture category growth.

Market Expansion: Nationwide rollout of services and continued hiring point to scaling capacity and broader geographic reach. Reports of expanded therapy and psychiatry availability indicate a wider operational footprint.

Strategic Partnerships: Collaborations with large channels and health platforms are described as widening referral pipelines and enterprise access. Case materials highlighting expanding health‑system referrals suggest deepening B2B traction.

Strong Revenue Growth: Independent coverage characterizes rapid top‑line acceleration and external recognition for multi‑year growth. These signals indicate momentum even as exact figures are not publicly audited.

Investor Backing & Capital Strength: A large late‑stage funding round led by prominent investors at a high valuation indicates strong capital support and confidence. Disclosures note the capital is allocated to scale core analytics, navigation, and incentives capabilities.

Strong Revenue Growth: Company communications and trade coverage consistently cite triple‑digit year‑over‑year revenue growth. This momentum is presented alongside broader traction markers around the funding announcement.

Market Expansion: Information provided indicates reach to millions of members across hundreds of organizations, spanning employers, plans, and providers. References to new channels and programs suggest a widening commercial footprint.

Investor Backing & Capital Strength: The company closed a $72 million Series C in 2024, bringing total funding to about $100 million to support expansion and technology investment. This capital base underwrites multi-state rollout and continued clinician hiring.

Market Expansion: Announcements detail entry into many additional states with a goal of being live in more than twenty by mid-2025. In-network arrangements with major health plans are cited as enabling broad access across much of the U.S.

Innovation-Driven Growth: The model emphasizes rigorous therapist matching, measurement-based care, and new AI investments to enhance care and reduce administrative burden. The launch of psychiatry broadens capabilities and supports scaling an integrated, tech-enabled service.